Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/ijms24098237
Keywords
endotheliopathy; biomarkers; COVID-19; long COVID
Ask authors/readers for more resources
The pulmonary endothelium performs various functions and plays a role in sepsis, acute respiratory distress syndrome, and COVID-19. Studies have examined the association between COVID-19 severity and outcomes and endothelial biomarkers, including markers of endothelial activation or injury. New biomarkers have been identified during the pandemic in addition to coagulopathy markers.
The pulmonary endothelium is a highly regulated organ that performs a wide range of functions under physiological and pathological conditions. Since endothelial dysfunction has been demonstrated to play a direct role in sepsis and acute respiratory distress syndrome, its role in COVID-19 has also been extensively investigated. Indeed, apart from the COVID-19-associated coagulopathy biomarkers, new biomarkers were recognised early during the pandemic, including markers of endothelial cell activation or injury. We systematically searched the literature up to 10 March 2023 for studies examining the association between acute and long COVID-19 severity and outcomes and endothelial biomarkers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available